Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Journal of Ovarian Research

Fig. 3

From: Development and validation of circulating CA125 prediction models in postmenopausal women

Fig. 3

Development and validation of the dichotomous CA125 prediction model. Receiver Operating Characteristic (ROC) curves were plotted and the Area Under the Curve (AUC) were calculated to assess the discriminatory performance of the dichotomous CA125 prediction model in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) (solid line) and Nurses’ Health Studies (NHS/NHSII) / New England Case Control Study (NEC) (dashed line)

Back to article page